Terazosin hydrochloride
- CAS No.
- 63074-08-8
- Chemical Name:
- Terazosin hydrochloride
- Synonyms
- Itrin;HYTRIN;Hitrin;Vicard;Blavin;Dysalfa;Flotrin;Heitrin;Hytrine;Olyster
- CBNumber:
- CB9285510
- Molecular Formula:
- C19H26ClN5O4
- Molecular Weight:
- 423.9
- MDL Number:
- MFCD00467965
- MOL File:
- 63074-08-8.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Melting point | 261-263°C |
|---|---|
| storage temp. | Inert atmosphere,2-8°C |
| solubility | H2O: 25 mg/mL |
| form | powder |
| color | white to off-white |
| Water Solubility | Soluble in water at 20mg/ml. Also soluble in methanol or ethanol. |
| Stability | Stable for 2 years as supplied. Solutions in distilled water may be stored at -20° for up to 3 months. |
| InChI | InChI=1S/C19H25N5O4.ClH/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H |
| InChIKey | IWSWDOUXSCRCKW-UHFFFAOYSA-N |
| SMILES | NC1=NC(N2CCN(C(C3OCCC3)=O)CC2)=NC2=CC(OC)=C(OC)C=C12.Cl |
| CAS DataBase Reference | 63074-08-8(CAS DataBase Reference) |
| NCI Dictionary of Cancer Terms | terazosin hydrochloride |
| FDA UNII | 8QOP8Z9955 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302 | |||||||||
| Precautionary statements | P264-P270-P301+P312-P501 | |||||||||
| PPE | dust mask type N95 (US), Eyeshields, Gloves | |||||||||
| Hazard Codes | Xn,Xi | |||||||||
| Risk Statements | 22-36/37/38 | |||||||||
| Safety Statements | 26-36 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | TK8044925 | |||||||||
| Storage Class | 11 - Combustible Solids | |||||||||
| Hazard Classifications | Acute Tox. 4 Oral | |||||||||
| NFPA 704 |
|
Terazosin hydrochloride price More Price(44)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | T4680 | Terazosin hydrochloride ≥98% (TLC), powder | 63074-08-8 | 50mg | $233 | 2026-04-30 | Buy |
| Sigma-Aldrich | T4680 | Terazosin hydrochloride ≥98% (TLC), powder | 63074-08-8 | 250mg | $1010 | 2026-04-30 | Buy |
| Cayman Chemical | 20216 | Terazosin (hydrochloride) ≥98% | 63074-08-8 | 100mg | $121 | 2026-04-30 | Buy |
| Cayman Chemical | 20216 | Terazosin (hydrochloride) ≥98% | 63074-08-8 | 250mg | $240 | 2026-04-30 | Buy |
| Cayman Chemical | 20216 | Terazosin (hydrochloride) ≥98% | 63074-08-8 | 500mg | $388 | 2026-04-30 | Buy |
Terazosin hydrochloride Chemical Properties, Uses, Production
Description
Terazosin hydrochloride is a highly water-soluble antihypertensive agent with a structure and profile closely related to that of prazosin.
Originator
Abbott (USA)
Uses
An α-1-adrenergicblocker related to prazosin.
Uses
Terazosin hydrochloride has been used for orthogonality and similarity analysis using reversed-phase chromatographic studies5. Furthermore, terazosin has also been used for the evaluation of chemometric techniques to determine orthogonality and similarity in chromatographic methods6.
Uses
Hytrin (Abbott).
brand name
Terazosin is INN and BAN;HEITRIN.
General Description
Terazosin hydrochloride, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine monohydrochloride (Hytrin), is a structuralcongener of prazosin hydrochloride. It possessessimilar selective properties of specifically inhibiting 1-adrenergic receptors. The drug is slightly less potent thanprazosin hydrochloride. Terazosin hydrochloride has a halflifeof approximately 12 hours, which is much longer thanthat of prazosin. This lends itself to a once-daily dose tocontrol hypertension in many patients.
Biological Activity
α 1 - and α 2B -adrenoceptor antagonist (K i values are 3.3, 0.7, 1.1, 7.7, 1510 and 78.2 nM for α 1A , α 1B , α 1D , α 2B , α 2A and α 2C receptors respectively). Antihypertensive following oral or intravenous administration in vivo .
Biochem/physiol Actions
α1-adrenoceptor antagonist.
storage
Store at RT
References
[1] A A HANCOCK. Actions of terazosin and its enantiomers at subtypes of alpha 1- and alpha 2-adrenoceptors in vitro.[J]. Journal of Receptors and Signal Transduction, 1995, 15 7-8: 863-885. DOI:10.3109/10799899509049862
[2] PH.D. J J K. Pharmacology of terazosin[J]. American Journal of Medicine, 1986, 80 5: Pages 12-19. DOI:10.1016/0002-9343(86)90846-6
[3] H SHIONOIRI. Long-term therapy with terazosin may improve glucose and lipid metabolism in hypertensives: a multicenter prospective study.[J]. American Journal of the Medical Sciences, 1994, 307 Suppl 1: S91-5.
[4] SHIOW-LIN PAN. Identification of Apoptotic and Antiangiogenic Activities of Terazosin in Human Prostate Cancer and Endothelial Cells[J]. Journal of Urology, 2003, 169 2: Pages 724-729. DOI:10.1016/s0022-5347(05)64002-5
[5] XINPING CHEN. Terazosin activates Pgk1 and Hsp90 to promote stress resistance[J]. Nature chemical biology, 2014, 11 1: 19-25. DOI:10.1038/nchembio.1657
Terazosin hydrochloride Preparation Products And Raw materials
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hainan Ludao Pharmaceutical Co., Ltd. | -- | ld@hngip.com | China | 1 | 60 |
| 3B Pharmachem (Wuhan) International Co.,Ltd. | 18930552037 | 3bsc@sina.com | China | 15813 | 69 |
| Adamas Reagent, Ltd. | 400-6009262 15618770481 | yhx@titansci.com | China | 14098 | 59 |
| Syntechem Co.,Ltd | info@syntechem.com | China | 12973 | 57 | |
| Beijing HuaMeiHuLiBiological Chemical | 010-56205725 | waley188@sohu.com | China | 12323 | 58 |
| Shanghai Aladdin Bio-Chem Technology Co.,LTD | 400-6206333 13167063860 | anhua.mao@aladdin-e.com | China | 29977 | 65 |
| Guangzhou Isun Pharmaceutical Co., Ltd | 020-39119399 18927568969 | isunpharm@qq.com | China | 4773 | 55 |
| AdooQ BioScience, LLC | +1 (866) 930-6790 | info@adooq.com | United States | 2774 | 58 |
| TargetMol Chemicals Inc. | 021-021-33632979 15002134094 | marketing@targetmol.com | China | 7993 | 58 |
| HBCChem, Inc. | +1-510-219-6317 | sales@hbcchem.com | United States | 10628 | 60 |
View Latest Price from Terazosin hydrochloride manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-08-21 | Terazosin hydrochloride
63074-08-8
|
$37.00-137.00 | 99.91% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2026-08-21 | Terazosin hydrochloride
63074-08-8
|
$37.00-137.00 | 99.91% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2026-08-12 | Terazosin hydrochloride
63074-08-8
|
$121.00 | 1KG | 99% | 200T | Baoji Guokang Healthchem Co., Ltd. |
-

- Terazosin hydrochloride
63074-08-8
- $37.00-137.00
- 99.91%
- TargetMol Chemicals Inc.
-

- Terazosin hydrochloride
63074-08-8
- $37.00-137.00
- 99.91%
- TargetMol Chemicals Inc.
-

- Terazosin hydrochloride
63074-08-8
- $121.00
- 99%
- Baoji Guokang Healthchem Co., Ltd.
63074-08-8 (Terazosin hydrochloride) Related Search:
1of4





